[go: up one dir, main page]

ATE227127T1 - Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes - Google Patents

Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes

Info

Publication number
ATE227127T1
ATE227127T1 AT96915595T AT96915595T ATE227127T1 AT E227127 T1 ATE227127 T1 AT E227127T1 AT 96915595 T AT96915595 T AT 96915595T AT 96915595 T AT96915595 T AT 96915595T AT E227127 T1 ATE227127 T1 AT E227127T1
Authority
AT
Austria
Prior art keywords
tripicolinate
chrome
diabetes
treatment
type
Prior art date
Application number
AT96915595T
Other languages
English (en)
Inventor
Mark F Mccarty
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 filed Critical Nutrition 21
Application granted granted Critical
Publication of ATE227127T1 publication Critical patent/ATE227127T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
AT96915595T 1995-05-12 1996-05-08 Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes ATE227127T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/440,362 US6329361B1 (en) 1995-05-12 1995-05-12 High-dose chromic picolinate treatment of type II diabetes
PCT/US1996/006493 WO1996035421A1 (en) 1995-05-12 1996-05-08 High-dose chromic tripicolinate for the treatment of type ii diabetes

Publications (1)

Publication Number Publication Date
ATE227127T1 true ATE227127T1 (de) 2002-11-15

Family

ID=23748461

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96915595T ATE227127T1 (de) 1995-05-12 1996-05-08 Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes

Country Status (15)

Country Link
US (1) US6329361B1 (de)
EP (1) EP0825861B1 (de)
JP (1) JP3699124B2 (de)
AR (1) AR004486A1 (de)
AT (1) ATE227127T1 (de)
AU (1) AU5733796A (de)
BR (1) BR9608835A (de)
DE (1) DE69624699T2 (de)
DK (1) DK0825861T3 (de)
ES (1) ES2183952T3 (de)
IL (1) IL118222A (de)
PT (1) PT825861E (de)
RU (1) RU2195934C2 (de)
WO (1) WO1996035421A1 (de)
ZA (1) ZA963735B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
AU751431B2 (en) * 1997-08-08 2002-08-15 Nutrition 21 Chromium/biotin treatment of type II diabetes
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
EP0925790A1 (de) * 1997-12-17 1999-06-30 Kartar Dr. Lalvani Vitamin- und Mineralzusammensetzungen zum Behandlung von X-Syndrom oder Insulin-unabhängigem Diabetes Mellitus
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
US6143301A (en) 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5948772A (en) 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5905075A (en) * 1998-08-28 1999-05-18 Ambi Inc. Chromium nicotinate compositions and uses thereof
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
AU6044699A (en) 1998-09-17 2000-04-03 Akesis Pharmaceuticals, Inc. Compositions and methods for treatment of glucose metabolism disorders
JP2004509143A (ja) 2000-09-21 2004-03-25 ニュートリション 21、インコーポレイテッド クロム錯体、共役脂肪酸及び/又は共役脂肪アルコールによる糖尿病の治療、体脂肪減少、インシュリン感受性の改善、高血糖症軽減及び高コレステロール血症軽減の方法及び組成物
AU2003226313A1 (en) * 2002-04-23 2003-11-10 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
EP1504762B1 (de) * 2002-05-14 2010-08-04 Nipro Corporation Medikament zur prävention und behandlung von familiärer amyloid polyneuropathie
US6831077B2 (en) * 2002-07-25 2004-12-14 Comprehensive Neuroscience, Inc. Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation
US20050019435A1 (en) * 2003-07-21 2005-01-27 Jeffrey Young Method of treating non-insulin dependent diabetes mellitus and related complications
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
CA3021932C (en) * 2007-01-31 2020-12-15 Jds Therapeutics, Llc Use of chromium histidinate for treatment of cardiometabolic disorders
PL2134351T3 (pl) 2007-03-13 2017-10-31 Jds Therapeutics Llc Sposoby i kompozycje do przedłużonego uwalniania chromu
WO2009002867A2 (en) * 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
EP3513790A1 (de) 2009-07-01 2019-07-24 JDS Therapeutics, LLC Chromkomplexe als enhancer von glucosetransportern im hirn
JP6152346B2 (ja) 2011-03-01 2017-06-21 ジェーディーエス セラピューティックス、エルエルシーJDS Therapeutics,LLC 糖尿病、低血糖、および関連障害の治療および予防のためのインスリンとクロムの組成物
MX2017010321A (es) 2015-02-13 2017-12-07 Mars Inc Sistema de alimentacion para mascotas.
EP3413900A1 (de) 2016-02-11 2018-12-19 Nutrition 21, LLC Chromhaltige zusammensetzungen zur verbesserung der gesundheit und fitness
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315927A (en) * 1980-08-08 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Dietary supplementation with essential metal picolinates
US5087623A (en) * 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US5164384A (en) 1991-06-19 1992-11-17 Metagenics, Inc. Anabolic mineral formula

Also Published As

Publication number Publication date
DE69624699D1 (de) 2002-12-12
EP0825861A1 (de) 1998-03-04
ES2183952T3 (es) 2003-04-01
IL118222A (en) 2000-06-01
EP0825861B1 (de) 2002-11-06
RU2195934C2 (ru) 2003-01-10
DE69624699T2 (de) 2003-03-20
IL118222A0 (en) 1996-09-12
WO1996035421A1 (en) 1996-11-14
MX9708628A (es) 1998-06-28
ZA963735B (en) 1997-01-09
AU5733796A (en) 1996-11-29
BR9608835A (pt) 1999-12-07
US6329361B1 (en) 2001-12-11
JP3699124B2 (ja) 2005-09-28
JPH11504941A (ja) 1999-05-11
PT825861E (pt) 2003-03-31
DK0825861T3 (da) 2003-03-03
AR004486A1 (es) 1998-12-16

Similar Documents

Publication Publication Date Title
ATE227127T1 (de) Hochdosiertes chromtripicolinat zur behandlung von typ-ii-diabetes
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE122007000002I2 (de) Pharmazeutische Zubereitung zur Verwendung in der Behandlung von Diabetes.
DE69817446D1 (de) Behandlung von diabetes
DE69710095D1 (de) Pharmazeutische zubereitung zur behandlung von diabetes
DE69612649D1 (de) Indolinonverbindungen zur behandlung von krankheiten
DE69609868D1 (de) Neue steroidester zur behandlung von hauterkrankungen
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE69307509D1 (de) Vorrichtung zur behandlung von herzfehlern
EP0709090A3 (de) Zusammensetzungen zur Behandlung von resistenten Tumoren
DE69804659D1 (de) 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69635708D1 (de) Tetrandrin zur behandlung von augenentzündungen
DE69527140D1 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69426848D1 (de) Gerät zur Behandlung von lichtempfindlichen Materialien
ATE221763T1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE68923219D1 (de) Behandlung von Abfällen.
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69806062D1 (de) Kombinationstherapie zur behandlung von aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69306260D1 (de) Behandlung von abwasser

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0825861

Country of ref document: EP

REN Ceased due to non-payment of the annual fee